← Eichor
Condition: Immune Dysregulation Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Immune Dysregulation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Natural History of Dysregulation and Aging of the Immune System in People With Trisomy 21 With and Without Thymectomy
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07416201Protective Effect of Thymosin Α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissecti
NA · 15 location(s) · Nanjing Medical University · NCT05339529Long-term Safety and Efficacy of Leniolisib in PIDs With Immune Dysregulation
Phase 2 · 4 location(s) · Pharming Technologies B.V. · NCT06990529Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study
Phase N/A · 2 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06339177Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositi
Phase N/A · 1 location(s) · National Institute of Arthritis and Musculoskeletal and Skin · NCT00059748Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC
EARLY_Phase 1 · 1 location(s) · Children's Hospital of Philadelphia · NCT02356653Immune Metabolism Dysregulation and Efficacy to Anti-PD-1 PD-L1 Agents in Non Small Cell Lung Cancer Patients
Phase N/A · 1 location(s) · Regina Elena Cancer Institute · NCT07637474Immune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung Disease
NA · 1 location(s) · Université Catholique de Louvain · NCT07384897Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma
Phase N/A · 3 location(s) · Henry M. Jackson Foundation for the Advancement of Military · NCT07652580SYSTEMS-LEVEL ANALYSES OF IMMUNE DYSREGULATION
Phase N/A · 1 location(s) · Karolinska Institutet · NCT06248957A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05027945Allergy and Immunology Natural History Study
Phase N/A · 1 location(s) · Columbia University · NCT05584488BfedBwell INSPIRE Pilot
NA · 1 location(s) · University of Colorado, Denver · NCT07446595Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifest
Phase 2 · 1 location(s) · Paul Szabolcs · NCT07284641Sensory Symptoms in Tourette Syndrome
Phase N/A · 2 location(s) · Vanderbilt University Medical Center · NCT03851484Stress Phenotypes and Preterm Birth
NA · 1 location(s) · Columbia University · NCT05229666Assessment of Metformin for Restoration of Immune Homeostasis in HIV+ and HIV- Individuals With a History of Injection D
Phase 4 · 1 location(s) · University of Alabama at Birmingham · NCT06829238Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
Phase N/A · 1 location(s) · Paul Szabolcs · NCT04528355Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT04339777Type 1 Diabetes and Obstructive Sleep Apnea
NA · 1 location(s) · University of Chicago · NCT06915831CD4^LVFOXP3 in Participants With IPEX
Phase 1 · 1 location(s) · Bacchetta, Rosa, MD · NCT05241444Immune Mechanisms and ECMO Strategies for Moderate-to-Severe ARDS
Phase N/A · 39 location(s) · Southeast University, China · NCT07726940Obesity, Metabolic Dysregulation and the Airway Epithelium in Asthmatics
NA · 1 location(s) · University of Colorado, Denver · NCT03215836Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
Phase 2 · 1 location(s) · Paul Szabolcs · NCT01962415Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
Phase 2 · 2 location(s) · National Cancer Institute (NCI) · NCT02579967Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
Phase 2 · 2 location(s) · National Cancer Institute (NCI) · NCT03922724
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.